Acesso livre
Acesso livre

Arquivos do dia: Outubro 4, 2022

Recomendações AAP | Prevenção de mortes e lesões pediátricas relacionadas a quadriciclos.

4 Out, 2022 | 12:42h

American Academy of Pediatrics Recommendations for the Prevention of Pediatric ATV-Related Deaths and Injuries – Pediatrics

Relatório técnico: A Comprehensive Report on All-Terrain Vehicles and Youth: Continuing Challenges for Injury Prevention – Pediatrics

Comentários:

ATVs Are Not Safe for Children: AAP Policy Explained – Health Children

AAP Calls for Prevention of Pediatric ATV-Linked Deaths, Injuries – HealthDay

 


Relatório clínico AAP | Controle e tratamento de piolhos em crianças e adolescentes.

4 Out, 2022 | 12:41h

Head Lice – Pediatrics

Comunicado de imprensa: American Academy of Pediatrics Updates Report on Controlling and Treating Head Lice in Children, Adolescents – American Academy of Pediatrics

 


Relatório clínico AAP | Avaliação de distúrbios de sangramento na suspeita de abuso infantil.

4 Out, 2022 | 12:40h

Evaluation for Bleeding Disorders in Suspected Child Abuse – Pediatrics

Relatório técnico: Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding – American Academy of Pediatrics

Comentário: AAP guidance helps distinguish bleeding disorders from abuse – MDedge

 


Estudo de coorte | Diabetes diagnosticado em adultos mais jovens está associado com morbidade aumentada em comparação ao diagnóstico feito em adultos mais velhos.

4 Out, 2022 | 12:39h

Associations of Age at Diagnosis and Duration of Diabetes With Morbidity and Mortality Among Older Adults – JAMA Network Open

 


Recomendações de consenso | Atividades prioritárias para abordar a lesão renal aguda em crianças.

4 Out, 2022 | 12:37h

Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children: A Modified Delphi Consensus Statement – JAMA Network Open

Comentário convidado: Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children – JAMA Network Open

 

Comentário no Twitter

 


M-A de estudos randomizados | Colchicina e riscos de doença cardíaca coronariana.

4 Out, 2022 | 12:36h

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

Conteúdos relacionados:

M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.

Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

 


Diretriz | Tratamento cirúrgico de abdome agudo após cirurgia bariátrica no ambiente de emergência.

4 Out, 2022 | 12:35h

Operative management of acute abdomen after bariatric surgery in the emergency setting: the OBA guidelines – World Journal of Emergency Surgery

Conteúdo relacionado: AGA clinical practice update on evaluation and management of early complications after bariatric/metabolic surgery.

 


Seguimento de longo prazo de um estudo randomizado | Monoterapia com inibidor de P2Y12 vs. terapia antiplaquetária dupla (dual antiplatelet therapy – DAPT) após intervenção coronariana percutânea.

4 Out, 2022 | 12:34h

Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link para o resumo – $ para o texto completo)

Estudo original: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention

 

Comentário no Twitter

 


Estudo randomizado | Intervenção comportamental entregue via mensagens de texto não reduziu as reinfecções por doenças sexualmente transmitidas em jovens.

4 Out, 2022 | 12:32h

Effectiveness of a behavioural intervention delivered by text messages (safetxt) on sexually transmitted reinfections in people aged 16-24 years: randomised controlled trial – The BMJ

Comunicado de imprensa: Texting young people about safe sex does not reduce STI reinfection – BMJ Newsroom

 

Comentário no Twitter

 


Breve revisão | Estratégia de sedação ótima para pacientes críticos.

4 Out, 2022 | 12:31h

Seeking the Light in Intensive Care Unit Sedation: The Optimal Sedation Strategy for Critically Ill Patients – Frontiers in Medicine

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.